Several animal studies discovered that curcumin, increase Phase II enzymes such as GSTs while decreasing the activity of VEGF (vascular endothelial growth factor) by inhibiting the receptor PPAR (peroxisome proliferator-activated) present in the colon cancer cells (11). Here, VEGFA is linked to malignant colon neoplasm.